RSS Feeds
Long-Term Reduction of Vascular Access–Associated Bloodstream Infection
- Philippe Eggimann, MD;
- Stéphane Hugonnet, MD, MSc;
- Hugo Sax, MD;
- Stephan Harbarth, MD, MS;
- Jean-Claude Chevrolet, MD; and
- Didier Pittet, MD, MS
- From University of Geneva Hospitals, 1211 Geneva 14, Switzerland.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background: Vascular access–associated infections remain a major complication of modern medicine (1). They increase patient morbidity, affect quality of patient care, and generate substantial hospital costs. Recently revised guidelines (2) have recommended education-based and staff training strategies as first-line prevention measures, but the long-term effect of these strategies has …
This 100-word excerpt has been provided in the absence of an abstract.
